Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gossamer Bio Inc.

1.24
-0.0300-2.36%
Post-market: 1.24-0.0001-0.01%18:28 EDT
Volume:1.13M
Turnover:1.40M
Market Cap:281.85M
PE:-5.48
High:1.29
Open:1.27
Low:1.20
Close:1.27
Loading ...

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
09 Apr

Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch?

Insider Monkey
·
27 Mar

Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5?

Insider Monkey
·
27 Mar

Gossamer Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Mar

Gossamer Bio Price Target Maintained With a $4.00/Share by Wedbush

Dow Jones
·
14 Mar

Piper Sandler Sticks to Their Buy Rating for Gossamer Bio (GOSS)

TIPRANKS
·
14 Mar

Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
14 Mar

Gossamer Bio: Q4 Earnings Snapshot

Associated Press Finance
·
14 Mar

Gossamer Bio Q4 2024 GAAP EPS $(0.15) Beats $(0.17) Estimate, Sales $9.379M Beat $6.834M Estimate

Benzinga
·
14 Mar

BRIEF-Gossamer Bio Q4 EPS USD -0.15

Reuters
·
14 Mar

Gossamer Bio: Prosera Phase 3 in Pah on Track for Topline Data Readout in Q4 of 2025

THOMSON REUTERS
·
14 Mar

Gossamer Bio Q4 EPS USD -0.15

THOMSON REUTERS
·
14 Mar

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Business Wire
·
14 Mar

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 Mar

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
08 Mar

With 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners

Simply Wall St.
·
03 Mar

Gossamer Bio Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
28 Feb

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 Feb

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
08 Feb

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Business Wire
·
03 Feb